4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Kojic acid/BVT-0019-M010/10 mg
商品详细Adipogen/Kojic acid/BVT-0019-M010/10 mg
Adipogen/Kojic acid/BVT-0019-M010/10 mg
Adipogen/Kojic acid/BVT-0019-M010/10 mg
商品编号: BVT-0019-M010
品牌: Adipogen Inc
市场价: ¥900.00
美元价: 540.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
Synonyms5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one;KOJ
ProductTypeChemical
Properties
FormulaC6H6O4
MW142.1
MerckIndex14:5317
CAS501-30-4
RTECSUQ0875000
Source/HostChemicalsIsolatedfromAspergillussp.
PurityChemicals≥99%(NMR)
AppearanceWhitesolid.
SolubilitySolubleinDMSO,methanolorwater.
IdentityDeterminedby1H-NMR.
DeclarationManufacturedbyBioViotica.
InChiKeyBEJNERDRQOWKJM-UHFFFAOYSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage+4°C
HandlingAdviceProtectfromlightwheninsolution.
Use/StABIlityStableforatleast1yearafterreceiptwhenstoredat+4°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Mycotoxin.ChelationagentwithpolyfunctionalskeletonfordevelopmentofBIOLOGicallyactivecompounds.
  • Moderateantibacterialagent.
  • Tyrosinaseinhibitor.Inhibitscatecholaseactivityoftyrosinase.
  • Anti-melanogenic.Skinwhiteningagent.
  • Antioxidant.Reactiveoxygenspecies(ROS)scavenger.
  • D-Aminoacidoxidase(DAAO)inhibitor.
  • ShowntoinhibitNF-kBactivation.
  • Inducerofmacrophageactivation.
  • RADIoprotectantactivity.
  • Antileishmanialagent.
  • Insecticidal.
  • Antifungalchemosensitizer.
  • Usedincosmeticsandasfoodadditive.
ProductReferences
  1. Thecontitutionofkojicacid,agamma-pyronederivativeofAspergillusoryzaefromcarbohydrates:T.Yabuta;J.Chem.Soc.125,575(1924)
  2. ToxicityandAntibioticActivityofKojicAcidProducedbyAspergillusluteo-virescens:H.E.Morton,etal.;J.Bacteriol.50,579(1945)
  3. Kojicacidscavengesfreeradicalswhilepotentiatingleukocytefunctionsincludingfreeradicalgeneration:Y.Niwa&H.Akamatsu;Inflammation15,303(1991)
  4. Kojicacid,acosmeticskinwhiteningagent,isaslow-bindinginhibitorofcatecholaseactivityoftyrosinase:J.Cabanes,etal.;J.Pharm.Pharmacol.46,982(1994)
  5. Thecombinationofglycolicacidandhydroquinoneorkojicacidforthetreatmentofmelasmaandrelatedconditions:A.Garcia&J.E.FultonJr.;Dermatol.Surg.22,443(1996)
  6. Kojicacid--anewleadingmoleculeforapreparationofcompoundswithananti-neoplasticpotential:L. Novotny,etal.;Neoplasma46,89(1999)(Review)
  7. Kojicacid,apotentialinhibitorofNF-kappaBactivationintransfectanthumanHaCaTandSCC-13cells:K.Y.Moon,etal.;Arch.Pharm.Res.24,307(2001)
  8. Effectsofmycotoxins,kojicacidandoxalicacid,onbiologicalfitnessofLygushesperus(Heteroptera:Miridae):J.Alverson;J.Invertebr.Pathol.83,60(2003)
  9. Frommiso,sakeandskoyutocosmetics:acenturyofscienceforkojicacid:R.Bentley;Nat.Prod.Rep.23,1046(2006)(Review)
  10. Kojicacidanditsmanganeseandzinccomplexesaspotentialradioprotectiveagents:S.Emami,etal.;Bioorg.Med.Chem.Lett.17,45(2007)
  11. Kojicacid,asecondarymetabolitefromAspergillussp.,actsasaninducerofmacrophageactivation:A.P.Rodrigues,etal.;CellBiol.Int.35,335(2011)
  12. SynthesisofkojicacidderivativesassecondarybindingsiteprobesofD-aminoacidoxidase:M.Raje,etal.;Bioorg.Med.Chem.Lett.23,3910(2013)
  13. Synergismofantifungalactivitybetweenmitochondrialrespirationinhibitorsandkojicacid:J.H.Kim,etal.;Molecules18,1564(2013)
  14. Anovelfunctionforkojicacid,asecondarymetabolitefromAspergillusfungi,asantileishmanialagent:A.P.Rodrigues,etal.;PLoSOne9,e91259(2014)
  15. AtyrosinaseinhibitorfromAspergillusniger:K.Y.Vasantha,etal.;J.FoodSci.Tech.51,2877(2014)
  16. ApplicationofFTIRmicrospectroscopyforcharacterizationofbiomolecularchangesinhumanmelanomacellstreatedbysesamolandkojicacid:M.Srisayam,etal.;J.Dermatol.Sci.73,241(2014)
  17. FeedingDeterrence,acutetoxicityandsublethalgrowtheffectsofkojicacidisolatedfromAspergillusfuniculosus:S.Busi,etal.;Nat.Prod.J.4,18(2014)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。